Oncology
4 articles
New blood test finds 14 proteins signaling lung cancer risk
A novel blood test can now identify a signature of 14 proteins, predicting an individual's lung cancer risk more than five years before diagnosis, according to Inside Precision Medicine .
Revolution Medicines Reports Promising Pancreatic Cancer Drug Results
Patients with previously treated metastatic pancreatic cancer lived an average of 13 additional months with Revolution Medicines' new drug, daraxonrasib, more than double the survival rate of standard
Pfizer Shares Updated Lung Cancer Bispecifics Data at ASCO
At the ASCO Annual Meeting, updated Phase 2 data for Pfizer's bispecific antibody PF-08634404 demonstrated activity as monotherapy in first-line PD-L1-expressing non-small cell lung cancer.
Gut Bacteria Enhance Cancer Therapy by Reprogramming T Cells
In a groundbreaking discovery, the presence of Segmented filamentous bacteria (SFB), a common gut bacterium, dictates whether anti-PD-1 immunotherapy successfully shrinks melanoma tumors.